Thank you.
I think your witnesses last week talked about the various pros and cons of models for registries. As one of the prior witnesses today said, that's not my area of expertise, but I do think that aspects of public oversight are extremely important here in terms of making these registries mandatory and making sure that clinicians report quickly, especially about adverse events, but also in making sure that recalls happen.
I think that the Australian registry is publicly funded, and this does not mean that the government runs it, of course. It means that the funding appears and is sent to managers of registries, such as universities in the case of Australia, and in other cases, it's sent to professional associations.
I think the question of who runs it is different from who funds it, but I think, too, that it inspires some confidence in Canadians and the Canadian public. I think there needs to be the heft of the Government of Canada behind such a registry, and I think that, fortunately, the one advantage of waiting 33 years to do this is that there are extremely good records and now investigations and reviews—